Compare Wegovy vs Mounjaro Mechanisms and UK Pricing
What's Best Wegovy or Mounjaro for UK Price-Conscious Patients?
When determining what's best between Wegovy or Mounjaro from a cost perspective, understanding the pricing structure becomes crucial for long-term treatment planning. Wegovy (semaglutide) operates as a single GLP-1 receptor agonist, requiring a structured dose escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist with its own escalation protocol. EverydayMeds offers the UK's most competitive pricing for both treatments, ensuring patients can access either option without compromising their budget or treatment quality.
The decision of what's best Wegovy or Mounjaro often comes down to individual response, tolerability, and ongoing affordability rather than mechanism alone. Both treatments require prescription through our qualified healthcare professionals and adherence to the licensed indication for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Our pricing structure reflects genuine value, incorporating clinical assessment, prescriber review, and next-day delivery within the quoted costs, ensuring transparency throughout your treatment journey.
Wegovy Pricing Structure: Complete UK Cost Breakdown
EverydayMeds provides the UK's lowest Wegovy prices through our streamlined service model and competitive pharmacy partnerships. Single pen pricing starts at £79.99 for the 0.25mg starter dose (after FIRST40 discount for new customers), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices include your clinical assessment, prescriber review, and temperature-controlled next-day delivery, representing exceptional value compared to traditional pharmacy channels. Returning customers benefit from the DOSE25 discount code, ensuring continued affordability throughout their treatment programme.
Our bundle options provide additional convenience for patients seeking uninterrupted treatment continuity. The Intro Trio (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first three months of dose escalation, whilst the Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99. These bundles eliminate the need for multiple orders whilst guaranteeing medication availability during critical treatment phases, particularly valuable given Wegovy's structured escalation requirements and the importance of maintaining consistent dosing schedules.
Clinical Evidence: What's Best Wegovy or Mounjaro Based on Trials?
The STEP clinical trial programme demonstrated Wegovy's efficacy in weight management when used alongside lifestyle interventions. In STEP 1, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 5 showed sustained clinically studied weight loss at two years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's clinical evidence stems from separate trial programmes with different patient populations and endpoints, making direct comparison inappropriate. Both treatments have demonstrated efficacy within their respective clinical contexts, and the question of what's best Wegovy or Mounjaro ultimately depends on individual patient factors, tolerability profiles, and prescriber assessment rather than head-to-head trial data.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones responsible for appetite regulation and glucose homeostasis. Once injected, semaglutide binds to GLP-1 receptors in the brain's appetite centres, particularly the hypothalamus, reducing hunger signals and promoting earlier satiety after meals. This mechanism may help patients consume smaller portions whilst feeling satisfied, supporting adherence to reduced-calorie dietary plans. The medication also slows gastric emptying, prolonging the feeling of fullness and potentially reducing food cravings throughout the day. As a prescription-only medicine, Wegovy requires careful dose escalation from 0.25mg to 2.4mg over 16 weeks, allowing the body to adapt gradually to the medication's effects whilst minimising potential side effects.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined ordering process begins with a comprehensive 3-minute online clinical assessment, evaluating your medical history, current medications, and suitability for Wegovy treatment. Following submission, our qualified prescribers review your assessment within three working days (or 24 hours with express service), ensuring appropriate prescribing according to MHRA guidelines and NICE recommendations. Upon approval, your prescription is dispensed through our GPhC-registered pharmacy (#9012878) and prepared for next-day delivery using specialised cold-chain packaging. Our temperature-controlled delivery system maintains the required 2-8°C storage throughout transit, ensuring medication integrity upon arrival. This integrated approach eliminates multiple appointments whilst maintaining clinical safety standards and regulatory compliance throughout the prescribing process.
Storage and Practical Considerations for Long-term Use
Wegovy requires refrigeration at 2-8°C before first use, offering a significant storage advantage with up to 6 weeks room temperature stability below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen delivery system provides precise dosing with a simple injection technique, suitable for once-weekly subcutaneous administration in the abdomen, thigh, or upper arm. Dose escalation follows a mandatory schedule: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg maintenance from week 17 onwards. This structured approach allows gradual adaptation whilst optimising therapeutic benefit, though patients cannot skip doses or accelerate the escalation schedule. The extended room temperature stability makes Wegovy particularly suitable for patients with active lifestyles or frequent travel requirements, reducing storage concerns compared to alternative treatments.
What's Best Wegovy or Mounjaro: Budget Planning for Extended Treatment
Understanding the long-term financial commitment becomes essential when evaluating what's best Wegovy or Mounjaro for sustained weight management. Wegovy's structured escalation to 2.4mg maintenance creates predictable monthly costs of £209.99 per pen after the initial dose-finding period, allowing accurate budget planning for extended treatment. Our bundle options provide cost-effective solutions for patients committed to longer treatment durations, with the Ultimate Stability Trio offering three months of maintenance supply. This pricing transparency helps patients make informed decisions about treatment sustainability without unexpected cost increases.
The question of what's best Wegovy or Mounjaro from a value perspective extends beyond simple price comparison to include consultation quality, delivery reliability, and ongoing prescriber support. EverydayMeds integrates these elements within our quoted prices, ensuring patients receive comprehensive care rather than medication-only supply. Both treatments require long-term commitment for optimal results, and our competitive pricing structure supports sustained treatment access without compromising clinical oversight or patient safety standards.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds with expert prescriber guidance to help determine the most suitable option for your circumstances. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25, ensuring continued access to the UK's lowest prices. Our integrated service includes clinical assessment, prescriber review, and next-day cold-chain delivery, providing exceptional value and convenience. Begin your assessment today at https://everydaymeds.co.uk/collections/wegovy to access expert weight management support with the UK's most competitive pricing. Remember that both treatments are prescription-only medicines requiring professional oversight and work most effectively alongside a reduced-calorie diet and increased physical activity as part of a comprehensive lifestyle approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
